Ella Ekholm (Former)

1 – 10 of 11

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/310356f6-88e7-4149-a2f6-b408da244fe3?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
next »

2016
Mark Safety, Pharmacokinetics and Pharmacodynamics of the Selective Glucocorticoid Receptor Modulator AZD5423 after Inhalation in Healthy Volunteers
Werkström, Viktoria ^LU ; Prothon, Susanne ; Ekholm, Ella ^LU ; Jorup, Carin and Edsbäcker, Staffan (2016) In Basic and Clinical Pharmacology and Toxicology 119(6). p.574-581
- Contribution to journal › Article
2013
Mark Alterations in bile acid synthesis in carriers of HNF1α mutations.
Ekholm, Ella ^LU ; Nilsson, Ralf ; Groop, Leif ^LU and Pramfalk, Camilla (2013) In Journal of Internal Medicine 274(3). p.263-272
- Contribution to journal › Article
Mark Impaired vibrotactile sense at low frequencies in fingers in autoantibody positive and negative diabetes.
Dahlin, E ; Ekholm, Ella ^LU ; Gottsäter, Anders ^LU ; Speidel, T and Dahlin, Lars ^LU (2013) In Diabetes Research and Clinical Practice 100(2). p.46-50
- Contribution to journal › Article
2012
Mark No signs of progressive beta cell damage during 20 years of prospective follow-up of autoantibody-negative diabetes.
Ekholm, Ella ^LU ; Gottsäter, Anders ^LU ; Dahlin, Lars ^LU and Sundkvist, Göran (2012) In Acta Diabetologica 49. p.57-62
- Contribution to journal › Article
Mark Metabolite Profiling Reveals Normal Metabolic Control in Carriers of Mutations in the Glucokinase Gene (MODY2).
Spégel, Peter ^LU ; Ekholm, Ella ^LU ; Tuomi, Tiinamaija ^LU ; Groop, Leif ^LU ; Mulder, Hindrik ^LU and Filipsson, Karin ^LU (2012) In Diabetes
- Contribution to journal › Article
2011
Mark Characterization of beta cell and incretin function in patients with MODY1 (HNF4A MODY) and MODY3 (HNF1A MODY) in a Swedish patient collection.
Ekholm, Ella ^LU ; Shaat, Nael ^LU and Holst, J J (2011) In Acta Diabetologica
- Contribution to journal › Article
2010
Mark An investigation of serum concentration of apoM as a potential MODY3 marker using a novel ELISA.
Cervin, Camilla ^LU ; Axler, Olof ^LU ; Holmkvist, Johan ^LU ; Almgren, Peter ^LU ; Rantala, E ; Tuomi, Tiinamaija ^LU ; Groop, Leif ^LU ; Dahlbäck, Björn ^LU and Ekholm, Ella ^LU (2010) In Journal of Internal Medicine 267. p.316-321
- Contribution to journal › Article
2008
Mark Can complement factors 5 and 8 and transthyretin be used as biomarkers for MODY 1 (HNF4A-MODY) and MODY 3 (HNF1A-MODY)?
Ekholm, Ella ^LU ; Shaat, Nael ^LU and Groop, Leif ^LU (2008) In Diabetic Medicine: A journal of the British Diabetic Association May 29. p.788-791
- Contribution to journal › Article
2007
Mark A variant in the transcription factor 7-like 2 (TCF7L2) gene is associated with an increased risk of gestational diabetes mellitus.
Shaat, Nael ^LU ; Lernmark, Åke ^LU ; Ekholm, Ella ^LU ; Ivarsson, Sten ^LU ; Parikh, Hemang ^LU ; Berntorp, Kerstin ^LU and Groop, Leif ^LU (2007) In Diabetologia 50(5). p.972-979
- Contribution to journal › Article
Mark MODY--en autosomalt dominant form av diabetes. Diagnos via gentestning ger bättre behandling
Ekholm, Ella ^LU and Groop, Leif ^LU (2007) In Läkartidningen 104(37). p.2600-2602
- Contribution to journal › Article

« previous
1
2
next »